Human Immunodeficiency Virus 1 Drug Resistance by Next Generation Sequencing
By report
Interpretive Data
Background information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results.
Refer to report
Compliance Category
FDA
Note
Additional information related to the test.
If Human Immunodeficiency Virus 1 by Quantitative NAAT result is greater than or equal to 2.70 log copies/mL, then HIV- Drug Resistance by Next Generation Sequencing will be added. Additional charges apply.
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
Other names that describe the test. Synonyms.
HIV genotyping for drug sensitivity testing
HIV-1 reflex to genotyping
HIV-1 Treatment decision
HIV-1 viral load
Nucleic Acid Amplification Test (NAAT)
Viral load monitoring
Human Immunodeficiency Virus 1 (HIV-1) by Quantitative NAAT with Reflex to HIV-1 Drug Resistance by Next Generation Sequencing
Chat
Feedback
